CRDF - Cardiff Oncology to Present at Upcoming Investor Conferences in May | Benzinga
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present at two upcoming investor conferences in May 2024.
Details of the presentations can be found below.
H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Location: The Nasdaq Headquarters, New York City
Presenter: Mark Erlander, CEO
Format: Fireside Chat
Date: 05/20/2024
Time: 2:30 PM ET
Cowen 5th Annual Oncology Innovation Summit: Insights for ...